ALBERT PEPRAH: Open Payments
NPI 1932822533 · WORCESTER, MA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,839 in 57 payments from 9 companies in 2025. Trend: 2023 $892 · 2024 $2,212 · 2025 $1,839
Food & beverage: $1,744Education: $96
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 12 | $327 |
| Vanda Pharmaceuticals Inc. | 20 | $292 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 6 | $282 |
| Alkermes, Inc. | 3 | $237 |
| ABBVIE INC. | 2 | $223 |
| E.R. Squibb & Sons, L.L.C. | 6 | $185 |
| Janssen Pharmaceuticals, Inc | 3 | $176 |
| Lundbeck LLC | 3 | $71 |
| Teva Pharmaceuticals USA, Inc. | 2 | $46 |
Products named: REXULTI, FANAPT, CAPLYTA, VRAYLAR, COBENFY, INVEGA SUSTENNA, ARISTADA, LYBALVI.
Industry payments across MA — which companies pay providers there.
